|
Volumn 9, Issue 3, 2008, Pages 286-294
|
The renin-angiotensin system and therapeutic vaccines for hypertension
|
Author keywords
Hypertension; Immunotherapy; Renin angiotensin system; Vaccine
|
Indexed keywords
ANGIOTENSIN 1 RECEPTOR;
ANGIOTENSIN 1 RECEPTOR ANTAGONIST;
ANGIOTENSIN I;
ANGIOTENSIN II;
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTIHYPERTENSIVE AGENT;
ATR 12181;
B LYMPHOCYTE ANTIGEN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
FREUND ADJUVANT;
MONOCLONAL ANTIBODY;
PEPTIDE VACCINE;
PMD 3117;
RENIN;
T LYMPHOCYTE ANTIGEN;
TETANUS TOXOID;
TUMOR NECROSIS FACTOR ALPHA ANTIBODY;
UNCLASSIFIED DRUG;
ACTIVE IMMUNIZATION;
ANTIBODY RESPONSE;
ANTIHYPERTENSIVE THERAPY;
BLOOD PRESSURE;
CELLULAR IMMUNITY;
CYTOTOXICITY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG SAFETY;
DRUG TARGETING;
DRUG TOLERABILITY;
HUMAN;
HYPERTENSION;
IMMUNE RESPONSE;
IMMUNOGENICITY;
NONHUMAN;
PASSIVE IMMUNIZATION;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
REVIEW;
T LYMPHOCYTE;
VACCINATION;
ANGIOTENSINS;
ANIMALS;
ANTIBODIES, BLOCKING;
HUMANS;
HYPERTENSION;
RECEPTOR, ANGIOTENSIN, TYPE 1;
RENIN;
RENIN-ANGIOTENSIN SYSTEM;
VACCINES;
|
EID: 40049085766
PISSN: 14724472
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (11)
|
References (67)
|